NEU 2.32% $19.40 neuren pharmaceuticals limited

Ann: Trading Halt, page-261

  1. 2,738 Posts.
    lightbulb Created with Sketch. 1062
    I think is is way to early for a takeover at a reasonable share price that the shareholders would accept.

    I am thinking that if the FDA has had visibility of the PMS Phase 2 results and they have similar efficacy as the pre-clinical mouse studies, then I am wondering if the FDA may have suggested a fast path for NNZ-2591 to get to PMS patients asap / quicker than planned. I am hoping this will be discussed on Monday as they results are announced.

 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.40
Change
-0.460(2.32%)
Mkt cap ! $2.489B
Open High Low Value Volume
$19.70 $19.77 $19.28 $8.793M 451.8K

Buyers (Bids)

No. Vol. Price($)
4 214 $19.40
 

Sellers (Offers)

Price($) Vol. No.
$19.41 95 8
View Market Depth
Last trade - 15.34pm 30/07/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.